Home / Companies / Impel Neuropharma Inc / Trends
Impel Neuropharma Inc H-1B trends
Quarterly LCA aggregate trend points for Impel Neuropharma Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Impel Neuropharma Inc span 2017 Q2 to 2022 Q2, peaking at 2 filings in 2017 Q2.
The most recent reported period (2022 Q2) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2017 Q2 | 2 | 1 | 1 | $74,520 | $67,517 | 1 | 50.0% |
| 2018 Q2 | 1 | 1 | 1 | $77,740 | $66,789 | 1 | 100.0% |
| 2019 Q2 | 1 | 1 | 1 | $77,740 | $68,910 | 1 | 100.0% |
| 2021 Q3 | 1 | 1 | 1 | $85,301 | $85,301 | 1 | 100.0% |
| 2022 Q2 | 1 | 1 | 1 | $110,094 | $110,094 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Impel Neuropharma Inc changed over time?
- H-1B LCA filings for Impel Neuropharma Inc span 2017 Q2 to 2022 Q2, peaking at 2 filings in 2017 Q2. The most recent reported period (2022 Q2) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=impel+neuropharma+inc&metric=lca_countJSON